← Back to headlines
Rocket Pharmaceuticals (RCKT) Boosted by FDA Approval of KRESLADI
Rocket Pharmaceuticals (RCKT) has seen a commercial boost following the FDA's approval of its drug KRESLADI.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
